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The Opioid Crisis: 
Are We Asking The 
Right Questions? 
Candace Robertson-James, DrPH
Danielle Sands, MPH
Opioid Use Disorders/ Addiction 
Opioids are a class of drugs that include the illicit drug heroin as well as 
the licit prescription pain relievers oxycodone, hydrocodone, codeine, 
morphine, fentanyl and others.1
Opioids interact with opioid receptors on nerve cells in the brain and 
nervous system to produce pleasurable effects and relieve pain.1
Symptoms include2:
strong desire for 
opioids
inability to control 
or reduce use
continued use 
despite 
interference with 
major obligations 
or social 
functioning
use of larger 
amounts over time
development of 
tolerance
withdrawal 
symptoms that 
occur after 
stopping or 
reducing use
1American Society of Addiction Medicine, (https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf) 2 https://www.samhsa.gov/disorders/substance-use  

Philadelphia Statistics
• As of July 2017, Philadelphia ranked 5th in overdoes 
deaths
• For all deaths in Philadelphia, overdoes is the leading 
cause, specifically due to the use of Fentanyl 
• In 2015, Philadelphia’s rate of 46.8 drug overdose deaths 
per 100,000 residents far outpaced other large cities, 
such as Chicago (15.4) and New York City (11.2)
• 80% of drug overdose deaths in Philadelphia involve 
opioids, including prescription opioids, heroin, and 
fentanyl.
McDaniel, J. (2017). Pa. overdose deaths again rise, but Philly no longer No. 1. Philadelphia, 
PA: The Inquirer.
The Mayor’s Task Force to Combat the Opioid Epidemic, 2017

Prescription Pain Reliever Misuse 
Figure 2. Main reasons for last episode of prescription pain reliever 
misuse among past year misusers aged 18 or older: 2015
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health (NSDUH), 
2015.
Figure 1. Past year misuse of prescription pain 
relievers among adults aged 18 or older: 2015
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey 
on Drug Use and Health (NSDUH), 2015
80% of people who use heroin first misused prescription opioids 
(Muhuri et al., 2013)
An estimated 4 - 6 % who misuse prescription opioids transition to heroin 
(Muhuri et al., 2013; Cicero et al., 2014; Carlson et al., 2016)
8 - 12% develop an opioid use disorder 
(Muhuri et al., 2013; Cicero et al., 2014; Carlson et al., 2016)

Medication Assisted Treatment & Overdose 
Prevention 
• Methadone, Buprenorphine, Naltrexone
• Naloxone can temporarily reverse an overdose that is caused by an 
opioid 
• Naloxone blocks effects of opioids on the brain & restores breathing 
within two to eight minutes 
• Philadelphia, naloxone has been widely used and distributed: 
• administered approximately 4,000 times by the Fire Department &
200 times by Philadelphia police in 2016.
Cases & Discussion 
Cases
Case 1  
Prescription 
Opioids & the 
Epidemic 
Case 2  
Naloxone –
Who pays for 
it?
Case 3       
ACES & 
substance 
misuse risk
Case 4 
Substance Use 
& Adolescence 
/ Young 
Adulthood
Case 5   
Syringe 
Exchange 
(Prevention 
Point)
Case 6 
Veterans & 
Opioid Misuse 
Risk 
HHS & NIH Priorities 
• Improving access to treatment and recovery services
• Promoting use of overdose-reversing drugs
• Strengthening our understanding of the epidemic through better 
public health surveillance
• Providing support for cutting-edge research on pain and addiction
• Advancing better practices for pain management
National Institute on Drug Abuse, 2017 
(https://www.drugabuse.gov/drugs-abuse/opioids/opioid-crisis#six) 
• Consumer directed media campaign about opioid risks
• Public education campaign about Naloxone
• Destigmatize opioid use disorder & its treatment
• Improve health care provider education 
• Establish insurance policies that support safer opioid 
prescribing and appropriate treatment
• Increase provision of medication assisted treatment
• Expand treatment access & capacity
• Implement warm handoffs to treatment after overdose
• Expand naloxone availability 
• Expand court’s capacity for diversion to treatment
Recommendations for Philadelphia 
Resources
• www.AmericanAddictionCenters.org (national)
• www.Discoveryplace.info (national)
• Tips for family and friends
• www.HealthyMindsPhilly.org (local)
• Support and programs for recovery
• www.PPPonline.org (local)
• Medical, shelter, meals, case management 
• http://www.thehealingway.net/
• https://www.addiction-treatment.com/find/opiate/philadelphia-pa/
